VIALE|C Study Design

VIALE-C Study Design - VENCLEXTA® (venetoclax tablets)

Indication. VENCLEXTA is indicated in combination with azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly diagnosed acute myeloid ...

A phase III study of venetoclax plus low-dose cytarabine in ...

7511Background: VIALE-C was designed to compare the safety and efficacy of the BCL-2 inhibitor venetoclax (VEN) or placebo (PBO) plus ...

Venetoclax plus low-dose cytarabine in patients with newly ...

In the 6-month follow-up analysis of the VIALE-C study, the addition ... Study design. This study was a single-arm, open-label ...

6-month follow-up of VIALE-C demonstrates improved and durable ...

Study design and patients. This randomized, double-blind, placebo-controlled, multicenter phase 3 study (NCT03069352) evaluated the efficacy and ...

Venetoclax plus LDAC for newly diagnosed AML ineligible for ...

Study design. This randomized double-blind placebo-controlled phase 3 study enrolled patients between May 2017 and November 2018. The study ...

NCT02993523 - ClinicalTrials.gov

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid ...

This confirmatory trial (VIALE-A) was designed to evaluate the ... design, trial conduct, analysis, and interpretation of the data. All ...

Review article Venetoclax with low-dose cytarabine, a forgotten ...

Study Design, Population, VEN/AZA and/or VEN/LDAC, Number of Patients ... It should also be noted that a subgroup analysis in the VIALE-C trial ...

Venetoclax combinations delay the time to deterioration of HRQoL in ...

Phase 3 trials Viale-A and Viale-C evaluated health ... Viale-A and Viale-C clinical trials. Materials and methods. Study design and patients.

M14-358 Clinical Trial Study Design - venclexta

Study M14-358 was a non-randomized, open-label trial (NCT02203773) that evaluated the efficacy and safety of VENCLEXTA (venetoclax tablets) in combination with ...

VIALE Studies in AML - OncLive

... studies are statistically kind of messed up. The reason you're not seeing the benefit is more because of disadvantageous study design with ...

AbbVie Provides Update from Phase 3 Study Evaluating ...

... VIALE-C trial. The trial was designed to evaluate the efficacy and safety of venetoclax in combination with low dose cytarabine (LDAC) (N ...

Design of the VIALE-M phase III trial of venetoclax and oral ...

VIALE-M is a randomized, double-blind, two-arm study to evaluate the safety and efficacy of venetoclax in combination with oral azacitidine (CC-486) as ...

Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic ...

We report primary analysis results from the CAPTIVATE MRD cohort evaluating disease-free survival (DFS) and treatment-free remission. Methods. Study Design and ...

Comparative Efficacy of Venetoclax-Based Combination Therapies ...

The results of the VIALE-A and VIALE-C trials,24,25 taken together ... Contributions to this study were made by Chenyang Gu (study design and data analysis) ...

VIALE-M: A Randomized, Double-Blind, 2-Arm, Multicenter, Phase III ...

AbbVie funded this trial and participated in the trial design, research, analysis, data collection, interpretation of data, and the review and approval of the ...

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Study Design and Patients. In this single-group, phase 2 study, eligible patients were 18 years of age or older; had received at least three ...

Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in ...

2.1 Patients and study design. Detailed procedures for the multicenter, phase 3, randomized, placebo-controlled, double-blind VIALE-A trial ...

Organizing Academic Research Papers: Types of Research Designs

The case study research design is also useful for testing whether a ... URL: https://library.sacredheart.edu/c.php?g=29803; Print Page. Librarian ...

Venetoclax combined with low dose cytarabine compared to ...

Analysis of clinical trials performed to date are promising for patients ... Study design. The VICTOR trial is an international, two-arm ...